Tycho Peterson is ranked #1846 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Tycho Peterson

JEF

Tycho Peterson

Q: How accurate are Tycho Peterson's stock ratings?

About 52% of Tycho's ratings were profitable over a one-year hold, with an average return of -0.2% per rating, measured by 13Foresight from historical prices.

Jefferies

Wall Street Analyst

★★★☆☆

#1846

on 13Foresight · ranked by our own returns

64%

Success Rate

+6.1%

Average Return

42 of 66 calls profitable · +44.8% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 64% of Tycho Peterson's ratings turned a profit when each position was held for 2 year — averaging +6.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

53 Buy 10 Hold 3 Sell

Tycho's Stock Coverage 56 ratings · 2026-08-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return	vs S&P 500 ⓘ
FRNM Freenome Inc	Aug 17, 2026	BUY	Strong Buy +25.2% avg upside 3 analysts	$17.00 25.50% Upside	·	·
NTRA Natera	Aug 17, 2026	BUY	Strong Buy -4.3% avg upside 27 analysts	$330.00 0.53% Upside	-0.8%	·
TXG 10x Genomics	Aug 07, 2026	BUY	Buy -33.8% avg upside 18 analysts	$53.00 14.93% Downside	+7.8%	·
QGEN Qiagen	Aug 06, 2026	BUY	Buy -1.9% avg upside 24 analysts	—	+2.9%	·
ES:BBVA Banco Bilbao Vizcaya Argentaria	Aug 04, 2026	BUY	Buy -34.9% avg upside 26 analysts	$27.50 12.29% Upside	+2.5%	·
MTD Mettler-Toledo	Jul 31, 2026	BUY	Buy -14.8% avg upside 18 analysts	$1580.00 10.30% Upside	+0.6%	·
AVTR Avantor	Jul 29, 2026	HOLD	Buy +10.8% avg upside 26 analysts	$13.00 7.98% Downside	-5.0%	·
DHR Danaher	Jul 27, 2026	BUY	Strong Buy +0.1% avg upside 45 analysts	$210.00 1.62% Downside	+7.6%	·
TMO Thermo Fisher	Jul 23, 2026	BUY	Strong Buy -1.2% avg upside 38 analysts	$630.00 1.82% Upside	+9.9%	·
DGX Quest Diagnostics	Jul 23, 2026	BUY	Buy -23.8% avg upside 34 analysts	$245.00 1.36% Upside	+2.9%	·
A Agilent	Jul 09, 2026	HOLD	Strong Buy -3.1% avg upside 33 analysts	$135.00 13.13% Downside	+18.0%	·
VCYT Veracyte	Jul 08, 2026	BUY	Strong Buy +21.0% avg upside 19 analysts	$70.00 67.49% Upside	-26.5%	·
ILMN Illumina	Jul 01, 2026	HOLD	Buy -12.9% avg upside 31 analysts	$150.00 27.89% Downside	+13.1%	·
WGS GeneDx Holdings	May 27, 2026	BUY	Strong Buy +0.8% avg upside 9 analysts	$100.00 22.99% Upside	+58.4%	·
BIO Bio-Rad Laboratories	May 21, 2026	HOLD	Strong Buy -1.8% avg upside 9 analysts	$275.00 24.78% Downside	+27.0%	·
QDEL QuidelOrtho	May 07, 2026	HOLD	Buy +184.0% avg upside 13 analysts	$12.50 9.77% Downside	+24.7%	·
TEM Tempus AI, Inc. Class A	Apr 12, 2026	SELL	Buy +8.4% avg upside 21 analysts	$35.00 46.80% Downside	-42.2%	·
CAI Caris Life Sciences, Inc.	Apr 12, 2026	BUY	Strong Buy +20.6% avg upside 20 analysts	$28.00 18.67% Upside	+9.6%	·
MLAB Mesa Laboratories	Mar 11, 2026	BUY	Buy +18.7% avg upside 5 analysts	$115.00 3.81% Downside	+31.8%	·
BRKR Bruker	Feb 12, 2026	BUY	Buy -2.2% avg upside 22 analysts	$50.00 14.86% Downside	+54.2%	·
WAT Waters	Feb 10, 2026	BUY	Strong Buy -4.8% avg upside 31 analysts	$470.00 14.13% Upside	+26.0%	·
RVTY Revvity	Feb 02, 2026	HOLD	Buy -9.1% avg upside 23 analysts	$105.00 12.31% Downside	+11.7%	·
MRK Merck & Company	Dec 19, 2025	BUY	Strong Buy -12.1% avg upside 43 analysts	$139.00 7.35% Downside	+52.8%	·
GH Guardant Health	Dec 17, 2025	BUY	Strong Buy +0.4% avg upside 31 analysts	$130.00 21.71% Downside	+73.1%	·
SERA Sera Prognostics	Dec 14, 2025	BUY	Strong Buy +274.3% avg upside 8 analysts	$5.00 151.27% Upside	-42.0%	·
BLLN BillionToOne, Inc. Class A	Dec 01, 2025	HOLD	Strong Buy +32.7% avg upside 9 analysts	$117.00 24.77% Upside	-22.2%	·
LH Labcorp Holdings	Jul 25, 2025	BUY	Strong Buy -17.8% avg upside 37 analysts	$300.00 9.44% Downside	+26.0%	·
ECL Ecolab	May 20, 2025	BUY	Strong Buy -0.1% avg upside 36 analysts	$310.00 9.04% Upside	+6.5%	·
CDXS Codexis	May 14, 2025	BUY	Strong Buy +528.0% avg upside 13 analysts	$4.50 175.18% Upside	-36.8%	·
PACB Pacific Biosciences	May 09, 2025	BUY	Buy +254.6% avg upside 14 analysts	$3.00 131.73% Upside	+13.4%	·
MYGN Myriad Genetics	Feb 25, 2025	SELL	Hold +429.5% avg upside 24 analysts	$11.00 243.77% Upside	+72.8%	·
NEO NeoGenomics	Feb 18, 2025	BUY	Buy +3.3% avg upside 18 analysts	$18.00 7.72% Upside	+28.1%	·
BLFS BioLife Solutions	Dec 16, 2024	BUY	Buy -18.2% avg upside 17 analysts	$31.00 15.23% Downside	+33.2%	·
CDNA CareDx	Aug 01, 2024	BUY	Buy -13.5% avg upside 17 analysts	$30.00 36.50% Downside	+85.4%	·
RGEN Repligen	Jun 03, 2024	HOLD	Strong Buy -1.0% avg upside 25 analysts	$165.00 7.55% Downside	-19.0%	·
MRVI Maravai Lifesciences Holdings	Jun 03, 2024	BUY	Strong Buy +96.4% avg upside 17 analysts	$11.00 40.49% Upside	-44.7%	·
NAUT Nautilus Biotechnolgy	Jun 03, 2024	HOLD	Strong Buy +1175.7% avg upside 5 analysts	$3.00 233.27% Upside	-4.8%	·
OSUR Orasure Technologies	May 13, 2024	HOLD	Buy +129.2% avg upside 11 analysts	$6.00 63.05% Upside	-41.1%	·
SHC Sotera Health	Jan 23, 2023	HOLD	Strong Buy +15.2% avg upside 13 analysts	$18.00 7.01% Downside	-20.9%	·
ICLR Icon	Apr 28, 2022	BUY	Strong Buy +9.2% avg upside 26 analysts	$315.00 81.28% Upside	+37.0%	·
RNLXY Renalytix	Apr 01, 2022	HOLD	Strong Buy +289.0% avg upside 5 analysts	$8.00 190.29% Upside	·	·
ABSI AbSci	Mar 23, 2022	BUY	Strong Buy +23.4% avg upside 18 analysts	$25.00 155.43% Upside	-34.3%	·
SOPH SOPHiA GENETICS	Mar 15, 2022	BUY	Strong Buy +27.4% avg upside 8 analysts	$18.00 118.42% Upside	-45.7%	·
RPID Rapid Micro Biosystems	Mar 04, 2022	BUY	Strong Buy +422.5% avg upside 6 analysts	$15.00 782.39% Upside	-82.8%	·
QTRX Quanterix	Mar 02, 2022	BUY	Buy +534.4% avg upside 8 analysts	$60.00 1867.26% Upside	-17.5%	·
SEER Seer	Mar 01, 2022	BUY	Strong Buy +450.3% avg upside 5 analysts	$25.00 1113.60% Upside	-86.8%	·
XRAY DENTSPLY SIRONA	Feb 28, 2022	HOLD	Buy +161.6% avg upside 25 analysts	$55.00 403.19% Upside	-36.6%	·
ADPT Adaptive Biotechnologies	Feb 16, 2022	BUY	Strong Buy -6.5% avg upside 15 analysts	$50.00 94.59% Upside	-75.1%	·
IQV IQVIA Holdings	Feb 15, 2022	BUY	Strong Buy -1.5% avg upside 39 analysts	$310.00 22.45% Upside	+5.6%	·
TWST Twist Bioscience	Feb 04, 2022	SELL	Strong Buy -34.6% avg upside 14 analysts	$65.00 52.75% Downside	+38.5%	·
ISRG Intuitive Surgical	Jul 21, 2021	BUY	Strong Buy +20.8% avg upside 36 analysts	$333.30 15.69% Downside	+6.9%	·
CRL Charles River Labs	May 28, 2021	BUY	Strong Buy -18.5% avg upside 35 analysts	$390.00 34.07% Upside	-42.6%	·
NVST Envista Holdings	Oct 30, 2020	BUY	Strong Buy +10.9% avg upside 19 analysts	$30.00 9.47% Upside	+25.8%	·
ARAY Accuray	Dec 13, 2017	SELL	Buy +1949.8% avg upside 9 analysts	—	+38.2%	·
PGEN Precigen	Mar 01, 2017	HOLD	Buy +250.9% avg upside 11 analysts	$25.00 256.07% Upside	-76.8%	·
TPST Tempest Therapeutics	Aug 04, 2016	HOLD	Buy +1938.5% avg upside 18 analysts	$8.00 644.32% Upside	·	·

🔒 51 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Tycho Peterson — Frequently Asked Questions

How accurate are Tycho Peterson's stock ratings?

Based on the calls 13Foresight could measure, about 52% of Tycho's ratings were profitable over a one-year hold, with an average return of -0.2% per rating, or +30.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Tycho ranked on 13Foresight?

Tycho Peterson is currently ranked #1846 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Tycho cover?

Tycho most recently has ratings on FRNM, NTRA, TXG, QGEN, ES:BBVA, MTD, AVTR, DHR, TMO, DGX, A, VCYT and 44 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Tycho Peterson

Rating Distribution

Welcome to 13Foresight!